Hawk Trade Enthuses over Nanotec Industries Diabetes Treatment

 

Contact Information
Hawk Trade


-
Japan
81345782731
info@hawktrade.co
 
Tokyo-based private fund, Hawk Trade is reportedly delighted with progress being made by one of the rising stars in its venture portfolio, Nanotec Industries after the firm published details of progress it has made during clinical trials with its diabetes treatment.

According to a spokesperson at Hawk Trade, the company has circumvented a problem, which had hampered its nano-based smart delivery system from effectively regulating glucose levels from within the body. The system would effectively take over the role performed by a pancreas which cannot produce insulin or the body is unable to make use of what it does produce.

“The system automatically regulates sugar levels rather than requiring a patient to conduct a finger prick test at varying intervals. There was a technical issue that they seem to have ironed out and that represents a major breakthrough,” said a Hawk Trade analyst.

Those suffering with diabetes face a perpetual battle to manage the effects of the condition. Daily self-management requires discipline and has many limitations including the inability to check glucose levels while asleep. The Nanotec Industries innovation, once fully tested, could be the first commercially available nanotechnology-powered treatment that could dramatically improve the quality of life for diabetics.

Hawk Trade said the company was also working on a breathalyser-type of detection system which uses nano-particles to detect acetone on the breath.

“The amount of acetone on the breath evidently bears a correlation to blood sugar levels and this could be a viable alternative in the future but this approach requires further research,” concluded the Hawk Trade analyst.

About Hawk Trade:
Since our inception in 2007, Hawk Trade has focused on delivering exceptional investment performance to our clients both corporate and individual, by coupling entrepreneurial drive with deep industry expertise and robust risk management.

About Nanotec Industries:
Nanotec Industries is dedicated toward the advancement of our revolutionary immuno-nanoparticle technology, which is making waves within the surgical field of medicine. We are making significant progress in the disciplines of tissue regeneration and disease detection, in addition to ground-breaking research projects in the biomedical sphere.

Nanotec Industries utilizes technology at the cutting-edge of science, from research faculties renowned for their innovation around Western Europe. Our ethos however is firmly intertwined with a far more traditional approach to medicine, taking our inspiration from Asian medicinal practices that have flourished for thousands of years.
For more information, visit: http://www.hawktrade.com


hawk trade, nanotec industries, nanotechnology, nanomedicine, funding, capital, venture capital, research, acetone, pancreas, glucose levels

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.